Posts

Showing posts from April, 2026

ONCO — On The Radar

ONCO (Onconetix, Inc.) Trading Notes Date: April 1, 2026 (Post-Market Close) Price: $1.875 ▲ +0.385 (+25.85%) Volume: 2.61M (Avg: 1.30M) Quick Take: Nice momentum day on the fresh CEO appointment and ongoing Realbotix humanoid robotics / 6G buzz. Low float (~656K) makes it explosive but extremely risky. Classic micro-cap swing setup after the 1-for-5 reverse split. 📊 Key Snapshot Metric Value Market Cap ~$1.34M Shares Outstanding ~716.85K Float ~655.94K 52-Week Range $1.17 – $74.29 P/B Ratio 0.0371 📈 Game Plan & Indicators Indicator Status Entry Signal RSI (14) ~50-52 (Neutral) Pullback to 40-45 or hold 50 S...

NTLA On The Radar

NTLA Trading Notes - April 2026 NTLA (Intellia Therapeutics) - Trading Notes Updated: Early April 2026 | CRISPR Gene Editing Biotech | Focus: lonvo-z (HAE) & nex-z (ATTR) Quick Market Snapshot Recent Price: ~$12.80 – $13.50 (closed ~$12.82 on Mar 31, +10% on high volume; volatile with recent +3–10% days). Market Cap: ~$1.5B | 52-Week Range: ~$5.90 – $28.25. Key Catalysts: HAELO Phase 3 topline data mid-2026 ; ATTR MAGNITUDE trial resumption post-FDA hold lift with enhanced liver monitoring. Analyst View: Moderate Buy, avg. PT ~$19–$25 (upside ~50–90% from current levels). Indicators to Watch for NTLA Events Fundamental/catalyst indicators drive big moves; technicals help with timing entries/exits. 1. Fundamental & Catalyst Indicators ...